Novo's GLP-1 Drug Shows Promise in Phase II for Type 2 Diabetes | Retatrutide News

Novo Nordisk's GLP-1 drug has reported positive Phase II results for Type 2 diabetes. This highlights the competitive landscape in GLP-1 agonist develop...
Clinical Trials · October 27, 2026